An Assessment of the Pharmacokinetics of a Sustained-release Formulation of a Tramadol/Acetaminophen Combination in Healthy Subjects
| Autor: | Eun Young Kim, Ji-Young Jeon, Soo-Wan Chae, Yunjeong Kim, Ji-Seok Yoo, Min-Gul Kim, Dae-Hee Shin, Yong-Jin Im, Dong-Joon Oh |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Chemistry Pharmaceutical Absorption (skin) Pharmacology Pharmacokinetics medicine Humans Pharmacology (medical) Tramadol acetaminophen Adverse effect Tramadol Acetaminophen Cross-Over Studies business.industry digestive oral and skin physiology Healthy subjects Analgesics Non-Narcotic Middle Aged Crossover study Healthy Volunteers Analgesics Opioid Drug Combinations Delayed-Action Preparations Anesthesia business Tablets medicine.drug |
| Zdroj: | Clinical Therapeutics. 37:376-389 |
| ISSN: | 0149-2918 |
| DOI: | 10.1016/j.clinthera.2014.12.007 |
| Popis: | Purpose To provide consistent pain relief and improve convenient sustained release (SR), a fixed-dose combination tramadol/acetaminophen tablet was formulated. This study aimed to evaluate the pharmacokinetic profiles of an SR 75-mg tramadol/650-mg acetaminophen formulation after a single dose compared with an immediate release (IR) 37.5-mg tramadol/325-mg acetaminophen formulation after 2 doses and at steady state and to assess the effect of food on the pharmacokinetic SR formulation profile after a single dose. Methods Two clinical trials were conducted: (1) an open-label, randomized, 3-period, 3-treatment, crossover study to assess the pharmacokinetic SR (one 75-mg tramadol/650-mg acetaminophen combination tablet) formulation profiles after a single dose and IR (one 37.5-mg tramadol/325-mg acetaminophen combination tablet q6h for 2 doses) formulation profiles after 2 doses and the effect of food intake on healthy male subjects and (2) an open, randomized, 2-period, 2-treatment multiple dose crossover study to evaluate the steady-state pharmacokinetic SR and IR formulation profiles. Safety assessments were performed. Findings Forty-three subjects completed each study protocol. The SR combination tramadol/acetaminophen formulation was clinically and statistically equivalent to the IR combination formulation in the fasting state. When tramadol and acetaminophen tablets were administered with food, the time to peak plasma concentrations and the tramadol/acetaminophen absorption were unaffected. There was no serious adverse event reported. Implications The SR combination tramadol/acetaminophen tablet exhibited similar exposure and absorption rates compared with those of the IR formulation of tramadol, O-desmethyltramadol, and acetaminophen. The SR formulation may be more convenient for patients and has the potential to enhance compliance and pain control. ClinicalTrials.gov identifier: NCT01880125 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect